Higher expressions of CDCA3 and UBE2C were significantly associated with higher histologic grades, but not with other clinical features, including age, clinical stage, lymphatic invasion, venous invasion, primary therapy outcome, personal tumor status, and vital status (Figure 9 and Supplementary Tables S1 and S2). This evidence concerns the gene UBE2C and neoplasm.